Barclays’s Translate Bio, Inc. Common Stock TBIO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q3 | – | Sell |
-48,208
| Closed | -$1.33M | – | 4229 |
|
2021
Q2 | $1.33M | Sell |
48,208
-49,587
| -51% | -$1.36M | ﹤0.01% | 1952 |
|
2021
Q1 | $1.61M | Sell |
97,795
-135,405
| -58% | -$2.23M | ﹤0.01% | 2033 |
|
2020
Q4 | $4.3M | Buy |
233,200
+160,161
| +219% | +$2.95M | ﹤0.01% | 1085 |
|
2020
Q3 | $994K | Buy |
73,039
+25,791
| +55% | +$351K | ﹤0.01% | 1929 |
|
2020
Q2 | $847K | Buy |
47,248
+35,746
| +311% | +$641K | ﹤0.01% | 2024 |
|
2020
Q1 | $115K | Sell |
11,502
-28,327
| -71% | -$283K | ﹤0.01% | 2776 |
|
2019
Q4 | $324K | Buy |
39,829
+21,316
| +115% | +$173K | ﹤0.01% | 2924 |
|
2019
Q3 | $183K | Sell |
18,513
-425
| -2% | -$4.2K | ﹤0.01% | 3105 |
|
2019
Q2 | $239K | Buy |
18,938
+10,090
| +114% | +$127K | ﹤0.01% | 3109 |
|
2019
Q1 | $90K | Buy |
8,848
+2,138
| +32% | +$21.7K | ﹤0.01% | 3385 |
|
2018
Q4 | $50K | Buy |
6,710
+3,039
| +83% | +$22.6K | ﹤0.01% | 3181 |
|
2018
Q3 | $37K | Buy |
+3,671
| New | +$37K | ﹤0.01% | 3823 |
|